# Top 50 Life Science Angel Investors in United States in June 2026 ## Sahin Boydas - Type: Angel - Location: San Francisco Bay Area, California, United States - Relevant deals: 6 - Stages: Seed, Series A, Series B - Focus: Software, Financial Services, Information Technology Sahin Boydas is the PEF Chapter Lead of PEF Community. He previously worked at RemoteTeam.com as CEO and Founder. Sahin Boydas attended Koç University, where he took a Bachelor of Science in Computer Engineering, and Bahcesehir University, where he took a Master of Business Administration in Entrepreneurship. ## Milad Alucozai - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 4 - Stages: Seed, Series A, Pre-Seed - Focus: Biotechnology, Health Care, Medical Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University. ## bumpkins profile - Type: Angel - Relevant deals: 4 - Stages: Seed, Series A, Pre-Seed - Focus: Health Care, Biotechnology, Robotics blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these. ## Darian Shirazi - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 3 - Stages: Seed, Series A, Series B - Focus: Software, Information Technology, Artificial Intelligence Darian Shirazi is the Managing Partner of Gradient. ## Kevin Moore - Type: Angel - Location: Dallas, Texas, United States - Relevant deals: 3 - Stages: Seed, Pre-Seed, Angel - Focus: Software, Health Care, E-Commerce Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates. ## Esther Dyson - Type: Angel - Location: New York, New York, United States - Relevant deals: 3 - Stages: Seed, Series A - Focus: Health Care, Software, Medical Esther Dyson - Founder @ Way to Wellville ## Chris Gibson - Type: Angel - Location: Salt Lake City, Utah, United States - Relevant deals: 3 - Stages: Series A, Seed - Focus: Biotechnology, Health Care, Life Science Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah. ## Erik Peterson - Type: Angel - Location: Chicago, Illinois, United States - Relevant deals: 3 - Stages: Seed, Equity Crowdfunding, Series A - Focus: Software, Biotechnology, SaaS Erik Peterson is the Founder at DormTrader. ## Jay Zaveri - Type: Angel - Location: San Francisco Bay Area, California, United States - Relevant deals: 2 - Stages: Seed, Series A - Focus: Biotechnology, Health Care, Software Jay Zaveri is based out of Menlo Park, California, and is the President and Board of Directors of Aether Bio and Founder and Partner of Natural Capital. ## Michael Chambers - Type: Angel - Location: Fargo, North Dakota, United States - Relevant deals: 2 - Stages: Series A - Focus: Biotechnology, Genetics, Life Science Michael Chambers is the Co-Founder at Agathos Biologics.Michael’s vision and leadership of Aldevron has resulted in several milestones including the 2004 acquisition of Genovac Antibody Technology of Freiburg, Germany; the 2009 expansion of protein production in Madison, Wisconsin; private equity transactions by TA Associates in 2017 and EQT in2020; and the purchase of Aldevron by Danaher for $9.6 billion in 2021. Michael is committed to ethical pharmaceutical development and his leadership will enable Agathos to create new paradigms in biotechnology to achieve these goals. Michael received Bachelor of Science degrees in biotechnology, chemistry, and microbiology from North Dakota State University. ## Sridhar Iyengar - Type: Angel - Location: Burlingame, California, United States - Relevant deals: 2 - Stages: Seed, Angel, Series A - Focus: B2B, Events, Travel A serial entrepreneur in connected medical devices and wearables, Sridhar is focused on strategy and management at Elemental Machines. Previously, Sridhar was a founder and director of Misfit, makers of elegant wearable products, which was acquired by Fossil in 2015. Prior to Misfit, he founded AgaMatrix, a blood glucose monitoring company thatmade the world’s first medical device connecting directly to the iPhone. AgaMatrix shipped 15+ FDA-cleared medical products, 2B+ biosensors, 6M+ glucose meters, with partnerships with Apple, Sanofi, and Walgreens. Sridhar holds over 30 US and international patents and received his Ph.D. from Cambridge University as a Marshall Scholar. Beyond Elemental Machines, Sridhar has been known to run 13.1 miles on occasion and has sometimes been spotted on stage behind a wall of drums. ## James Hong - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 2 - Stages: Seed, Series A, Angel - Focus: E-Commerce, Mobile, Internet James Hong ## Nitesh Banta - Type: Angel - Location: New York, New York, United States - Relevant deals: 2 - Stages: Seed, Series A, Pre-Seed - Focus: Software, Artificial Intelligence, Information Technology Nitesh Banta is the Co-Founder & CEO at B12. ## Jeff Dean - Type: Angel - Location: Palo Alto, California, United States - Relevant deals: 2 - Stages: Seed, Series A, Pre-Seed - Focus: Artificial Intelligence, Information Technology, Software Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award. ## Craig Mundie - Type: Angel - Relevant deals: 2 - Stages: Seed, Series B, Series C - Focus: Life Science, Chemical, Genetics Craig Mundie is chief research and strategy officer of Microsoft Corp., reporting to CEO Steve Ballmer. In this role, he oversees Microsoft Research, one of the world’s largest computer-science research organizations, and is responsible for Microsoft’s long-term technology strategy. Mundie also directs a number of technology incubations, and workswith government and business leaders around the world on technology policy, regulation and standards.Mundie has spent much of his career building startups in various fields, including supercomputing, consumer electronics, education, healthcare and robotics. He joined Microsoft in 1992 to create and run the Consumer Platforms Division, which developed non-PC platforms such as the Windows CE operating system; software for the Handheld PC, Pocket PC and Auto PC; and early console-gaming products. Mundie also started Microsoft’s digital-TV efforts, acquiring and managing its WebTV Networks subsidiary, and built its fast-growing healthcare solutions business.Prior to his current role, Mundie served as Microsoft’s chief technical officer for advanced strategies and policy, working with Microsoft Chairman Bill Gates to develop the company’s global strategies around technical, business and policy issues. Another long-standing focus for Mundie is privacy, security and cyber-security. He initiated Microsoft’s Trustworthy Computing initiative, which has leveraged new software-development practices to significantly improve the security of the company’s products.For more than a decade, Mundie has also been Microsoft’s principal technology-policy liaison to the U.S. and foreign governments, with an emphasis on China, India and Russia. He has served on the U.S. National Security Telecommunications Advisory Committee and the Markle Foundation Task Force on National Security in the Information Age. In April 2009 Mundie was appointed by President Barack Obama to the President’s Council of Advisors on Science and Technology.Mundie started his career in 1970, working on operating-system development for the Data General NOVA at Systems Equipment Corp. (SEC) while still studying at Georgia Tech. SEC was subsequently acquired by Data General Corp., where Mundie went on to develop the INFOS data-management system. In 1977 Mundie moved to Data General’s advanced development facility in Research Triangle Park, N.C., ultimately becoming its director. In 1982, Mundie was one of three co-founders of Alliant Computer Systems Corp., which developed vector-parallel mini-supercomputers. He held a variety of positions at Alliant before becoming CEO. The company shut down in 1992.Mundie holds a bachelor’s degree in electrical engineering and a master’s degree in information theory and computer science from Georgia Tech. Mundie enjoys traveling and spending time on his boat. He is married, with one married daughter. ## Avichal Garg - Type: Angel - Location: Stanford, California, United States - Relevant deals: 2 - Stages: Seed, Series A - Focus: Software, Blockchain, Internet Avichal is Managing Partner at Electric Capital. He is a serial entrepreneur and technology executive. Avichal sold two companies and was most recently Director of Product at Facebook, which acquired his company Spool in 2012. He previously worked at Google on search ranking and ads ranking, is part-time at YCombinator, and an active angelinvestor.Avichal's firm, Electric Capital, focuses on cryptocurrencies that are rooted in technological utility. Electric performs deep technological diligence, such as compiling code, profiling nodes, and analyzing blockchains with in-house software. The founders of Electric have started and sold five companies, have been investing in cryptocurrencies since 2013, and are investors in Anchor, Bitwise, Chia, Coda, dYdX, Dfinity, Oasis, Thunder and many other crypto projects. ## Alec Nielsen - Type: Angel - Location: Cambridge, Massachusetts, United States - Relevant deals: 2 - Stages: Seed, Pre-Seed - Focus: Biotechnology, Biopharma, Medical Alec Nielsen is the Founder & CEO at Asimov. ## Elad Gil - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 2 - Stages: Seed, Series A, Series B - Focus: Software, Information Technology, Artificial Intelligence Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology. ## Nat Turner - Type: Angel - Location: New York, New York, United States - Relevant deals: 2 - Stages: Seed, Series A, Series B - Focus: Health Care, Software, Medical Nat Turner is based out of New York, New York, and is the CEO and Chairman of Collectors. Nat previously worked at OneOncology as a board member. Nat Turner attended the Wharton School of the University of Pennsylvania. ## Katie Haun - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 2 - Stages: Seed, Series A - Focus: Blockchain, Financial Services, FinTech Katie is the founder and CEO of Haun Ventures, a Silicon Valley venture fund that manages billions in investments across frontier technologies including blockchain and digital assets. The firm’s institutional investors are major sovereign wealth funds, endowments, foundations, financial institutions, and other global organizations.She has servedas a board member of several high-growth technology companies. As Coinbase’s first independent director, she was an early architect of company’s global regulatory strategy, serving through its direct listing and subsequent growth as a publicly traded company. During her tenure from 2017 to 2024, she held several positions including Chair of the Nomination and Governance Committee, Chair of the Audit and Risk Committee, and member of the Compensation Committee.Katie joined Andreessen Horowitz as a General Partner in 2018. There, she co-led their crypto franchise, building a team and investing out of three successive funds with billions under management, generating significant realized returns for institutional investors.Before her venture career, Katie spent over a decade as a federal prosecutor with the U.S. Department of Justice. She secured successful jury verdicts in every case she tried and led high-profile prosecutions related to the Silk Road task force, the 2012 Hells Angels murder trial, and the Nuestra Familia prison gang RICO takedown. She also led cyber, corporate, and violent crime investigations in partnership with the FBI, Homeland Security, SEC, and Treasury. At DOJ headquarters, she held senior leadership positions in the National Security Division and later the Attorney General’s office where her portfolio covered antitrust, tax, and national security matters. Katie represented DOJ on both CFIUS and the FBI’s Undercover Review Committee, that approved significant undercover operations.Katie has been profiled by Bloomberg, Fortune, The New York Times, and CNBC and was named one of Bloomberg BusinessWeek’s 50 Most Influential in 2022. ## CJ Reim - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 2 - Stages: Series A, Seed, Series D - Focus: Robotics, E-Commerce, SaaS CJ Reim is a co-founder of Amity Ventures and an active investor in Avochato, Carta, Ouster, Talkdesk, and more than 15 other growing technology businesses. CJ is currently focused on investments in software, fintech, and consumer sectors, and represents Amity on the boards of Avochato and MaintainX.Prior to Amity, CJ was a Vice President on theinvestment team at Highland Capital Partners, where he focused on technology investments across all stages of company growth. He also led the Summer@Highland entrepreneurship program which, over its nine-year history, has mentored 50 student-led startups from inception. CJ is originally from Minnesota and holds a B.S. in Management with concentrations in Finance and Information Systems from Boston College. Outside of Amity, CJ enjoys CrossFit, freediving, and downhill skiing. ## David R. Walt - Type: Angel - Location: Boston, Massachusetts, United States - Relevant deals: 2 - Stages: Seed, Series A, Series B - Focus: Biotechnology, Genetics, Life Science David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT. ## Jonathan Milner - Type: Angel - Location: Cambridge, Massachusetts, United States - Relevant deals: 2 - Stages: Seed, Series A, Series B - Focus: Biotechnology, Health Care, Medical Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs. ## Lars Fjeldsoe-Nielsen - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 2 - Stages: Seed, Series A, Series B - Focus: Software, Information Technology, Mobile Apps Lars Fjeldsoe-Nielsen grew up across Africa, from Angola and Guinea-Bissau to Tanzania and Libya, after his family fled the Angolan Civil War as refugees. Those early experiences instilled in him a belief that education, technology, and social innovation can transform lives and continue to anchor his career and philanthropic activities to this day.Today, Lars is a General Partner at Owl Ventures ($2.2 billion AUM), the world’s leading venture capital firm focused exclusively on education technology. He leads Owl’s expansion across Europe, Africa, and global markets, backing founders who harness AI and breakthrough technologies to make learning more accessible and impactful.Before joining Owl, Lars co-founded 2xN, an early-stage fund at the frontier of deeptech and quantum innovation, with standout investments including Quantinuum (valued above $10 billion), Oxford Ionics (acquired by IonQ in a $1 billion deal), QSimulate, and Sparrow Quantum. Prior to that, he was a General Partner at Balderton Capital in London during which time the firm led the Seed and Series A rounds in Revolut. His investments also span education (Labster, uLesson, StudySmarter, Kukua), mobility (Yassir, Voi, Monta, NoTraffic), and mobile and frontier tech (Hiya, Monarch Money, Rahko, Pocket, Colossal, Celus, Octant Bio, Vivino, OpenSea, Blue Bottle Coffee).Lars previously spent a decade in Silicon Valley, shaping some of tech’s most iconic growth stories. At Uber, he joined when it operated in fewer than 20 cities and, as Vice President, forged global alliances with Verizon and América Móvil that fueled its international expansion. Before Uber, as Head of Mobile at Dropbox, he was among the first 25 employees and helped the company reach its first 100 million users through partnerships with Samsung and other OEMs.Despite his career in technology and venture capital, Africa has never left Lars’s journey. After his father’s passing, he returned to Angola to trace his family’s history, discovering that his sister had died of malaria as a child. That revelation transformed a personal loss into a mission. A technologist turned humanitarian innovator, Lars filed a patent for genetically modified mosquitoes that light up when carrying malaria and began funding malaria-research projects in Angola through partnerships with global nonprofits. In 2024, he climbed Mount Kilimanjaro to raise funds for malaria research, following earlier campaigns such as climbing the Matterhorn and crossing the Sahara by motorbike.A Danish-Portuguese national who served with the Royal Danish Guards, Lars holds an MBA from London Business School, where he was a member of the Board of Governors and Chairman of the Endowment Fund, an MSc from Oxford University (Keble College), and a BSc from King’s College London. Across every chapter, from refugee to technologist to investor, his purpose endures: advancing education, health, and innovation as catalysts for social change. ## Kevin Mahaffey - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 2 - Stages: Seed, Series A, Pre-Seed - Focus: Software, SaaS, Artificial Intelligence Kevin Patrick Mahaffey is the Founder of Lookout and SNR. He is also the Executive Chairman of Stork Club and an Investor. ## Peter Harris - Type: Angel - Relevant deals: 2 - Stages: Seed - Focus: Life Science, Biotechnology, Health Diagnostics Peter Harris ## Zach Weinberg - Type: Angel - Location: New York, New York, United States - Relevant deals: 2 - Stages: Seed, Series A, Pre-Seed - Focus: Software, Health Care, SaaS Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania. ## Joe Betts-Lacroix - Type: Angel - Location: San Francisco Bay Area, California, United States - Relevant deals: 2 - Stages: Seed - Focus: Life Science, Biotechnology, Pharmaceutical Joe Betts-Lacroix is the Founder and CEO of Retro. He previously worked at Recursion as an Advisor. Joe Betts-Lacroix attended Harvard University. ## Balaji Srinivasan - Type: Angel - Location: San Francisco Bay Area, California, United States - Relevant deals: 2 - Stages: Seed, Series A, Pre-Seed - Focus: Blockchain, Cryptocurrency, Software Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC. ## Sujay Jaswa - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 2 - Stages: Seed, Series B, Series A - Focus: Software, FinTech, Financial Services Sujay Jaswa is founder and managing partner at WndrCo, a holding company that invests in and acquires consumer technology businesses. He serves as Chairman of Aura, Twingate, VPN Super, and is a Director of The Infatuation. Board member of Vy Global Growth (Nasdaq: VYGG). Advisor at Seven1 Sports & Entertainment Agency. He is also a lecturerat the Stanford Graduate School of Business. He formerly served as business founder, vice president of business, and CFO of Dropbox from 2010 to 2015. At Dropbox, Sujay created and led the global business and finance organization. He has a Bachelor’s degree in Economics from Princeton University and an MBA from Harvard Business School. ## Mei Z. - Type: Angel - Location: San Francisco Bay Area, California, United States - Relevant deals: 2 - Stages: Seed, Pre-Seed, Series A - Focus: Artificial Intelligence, Software, Information Technology Mei is an early stage investor focused on AI. Mei studied at MIT and the MIT Media Lab ## Joshua Elkington - Type: Angel - Relevant deals: 2 - Stages: Seed - Focus: Biopharma, Life Science, Biotechnology Joshua Elkington ## Ankit Jain - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 2 - Stages: Seed, Pre-Seed - Focus: Health Care, Medical, Hospital Ankit Jain is the Founder and CEO of Infinitus Systems. ## Patrick Collison - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 2 - Stages: Series A, Seed, Series C - Focus: Software, Artificial Intelligence, Information Technology Patrick Collison is a CEO of Stripe. ## Patrick Yang - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 2 - Stages: Series A, Seed, Series B - Focus: Software, Health Care, Artificial Intelligence Patrick Yang, General Partner at Amity Ventures, has led the firm’s investments in CaptivateIQ, Evisort, Flick, MoQuality, TruePill, and Vowel. He sits on the boards of Evisort and MoQuality. His primary areas of investment focus include AI, consumer, logistics, mobility, and software. Patrick co-founded Amity Ventures with CJ Reim in 2017 afterthe two worked together at Highland Capital Partners.Prior to Amity, Patrick was a Vice President at Highland, where he sourced the firm’s investment in nuTonomy, an autonomous vehicle startup acquired by Delphi one year later for $450M. Patrick is from the Bay Area and holds a B.S. in Business Administration with a concentration in Engineering Leadership from University of California, Berkeley.Pat currently serves on the board of Advancing Women in Product, a non-profit that empowers women to enter and succeed in product management roles. In his free time, he enjoys hiking and eating in the San Francisco area, and attending sporting events—especially Warriors, 49ers, and Giants games. ## Brian S. Cohen - Type: Angel - Location: New York, New York, United States - Relevant deals: 2 - Stages: Seed, Series A - Focus: Software, SaaS, Mobile Considered one of the fathers of science & technology strategic communications - founded Technology Solutions, Inc. in 1983. Client list read like a who's who list of startup technology companies in computing, communication, software, education, and entertainment. Maintained a strategic communications partnership with Sony & IBMCorporation (10 years). Received the Gold CIPRA award in 1998 for the IBM Deep Blue/Gary Kasparov Chess Match. In 1996, TSI was recognized as the #1 fastest growing agency in the United States. Sold the company to The McCann Erickson World Group in 1997 and became the Vice Chairman. Created Focus Technology, an organization that provided qualitative research and instituted the RPM model of integrated strategic communications providing ultra-competitive technology clients the ability to quickly discover and leverage their key strengths as well as mitigate their destructive weaknesses.Brian was a pioneer in the founding of a number of the first computing publications including Computer Systems News and InformationWeek magazine. Now serves as Chairman of the New York Angels. He is very devoted to the New York City startup community.Developed the AIMS (Applied Internet Media Studies) Program, a senior/graduate level college semester program where students will be rigorously trained to use the internet professionally.Frequent speaker on strategic communication, entrepreneurism and early startup investing. Now writing a book for McGraw Hill - a new organizational product launch model.Received the Distinguished Alumnus Award, holds a Masters Degree in Science Communications from Boston University's School of Communications. ## Thomas Tull - Type: Angel - Relevant deals: 1 - Stages: Series A, Seed - Focus: Artificial Intelligence, Software, Machine Learning Thomas Tull is the founder, chairman, and chief executive officer of Legendary Entertainment, a media company that produces content for mainstream audiences. ## Nimi Katragadda - Type: Angel - Location: New York, New York, United States - Relevant deals: 1 - Stages: Seed, Pre-Seed, Series A - Focus: Life Science, Biotechnology Nimi Katragadda is an investor at BoxGroup, which is a seed stage venture fund that invests in entrepreneurs building companies with visions to create the next generation of category defining businesses. Prior to joining BoxGroup, Katragadda worked at Google and J.P. Morgan. She holds a MBA from Harvard Business School and a BA in Economics fromHarvard. ## Dilek Dayinlarli - Type: Angel - Location: San Francisco Bay Area, California, United States - Relevant deals: 1 - Stages: Seed, Pre-Seed - Focus: Software, iOS, Transportation Dilek was actively investing as an angel and being an active chairwomen since 2017. She has been an angel investor in companies like Picus Security, DataRow (acquired by AWS), Genomize, and Genialis, having a board seat on multiple of them.Previously she was an investor at 212, an early-stage technology venture capital in İstanbul. She investedin companies like IyziCo, the biggest Fintech company in the region and Insider, global marketing automation software, funded by Sequoia Capital and so on.Prior to 212, Dilek worked at Groupon as Director of Strategy and Analysis, Management Consultant at Accenture and Business Developer at Koc Group. She started her career in the USA, where she held different project management positions and also started her own startup.Dilek received a BA honors degree in Mechanical Engineering from Yildiz Technical University and MBA from Johnson & Wales University, both with honor degrees. Dilek is also one of the first Kauffman Fellows, chosen from Turkey and distinguished by scholarship. She is also a founding member and leader of Arya Women Investment Platform. She is a guest lecturer at Stanford University and a judge at European Commission. Dilek was awarded as One of the Most Successful Women Leaders in Turkey, thanks to her contributions and impact on tech industry.Outside the office, Dilek loves to experience authenticity in new destinations. She is a competitive basketball player, a serious artwork collector, and an avid reader of books. She puts deliberate effort to spend quality time with her loving family and friends; informative pastry cooking sessions with her daughter, sophisticated board games while drinking coffee with relatives and friends, or book clubs to foster intellectual curiosity between friends and colleagues. She also jumps every morning to find the leaders of future who will be able to create big impact and help them at their journey. It is fascinating to witness how her life outside the office enriches her work as an investor. ## Nathalie Gaveau - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 1 - Stages: Series A, Seed, Pre-Seed - Focus: Retail, Genetics, Internet Nathalie Gaveau is the Président of Tailwind International. She is a graduate of MIT Sloan School of Management and HEC Paris. ## Chuck Farkas - Type: Angel - Location: Boston, Massachusetts, United States - Relevant deals: 1 - Stages: Private Equity - Focus: Genetics, Life Science, Biotechnology Charles Farkas became an Advisory Partner at Bain & Company in July, 2015. Prior to that he was a Senior Partner in Bain & Company’s Boston office. He joined the firm in 1979 and was elected to the partnership in 1985. Mr. Farkas advises chief executives and senior managers in a wide variety of industries on issues critical to long-termsuccess. He has served as the global leader of Bain & Company’s Financial Services practice, the North American head of Bain’s Healthcare practice and as the Managing Director of Bain Canada.He has worked globally with companies in a wide range of industries including healthcare providers and suppliers, banking, insurance, brokerage, credit cards, consumer goods, retailing and industrial products.With over 36 years of experience, Mr. Farkas is highly sought out by clients for his experience with issues of growth, strategy, leadership and change. He is the author of the best-selling book Maximum Leadership (1996) and numerous articles published in the Harvard Business Review, Fortune, In Vivo and other publications. In 2008 Consulting Magazine named Mr. Farkas one of the Top 25 Global Consultants. ## Timothy A. Springer - Type: Angel - Location: Cambridge, Massachusetts, United States - Relevant deals: 1 - Stages: Series A, Series B, Seed - Focus: Biotechnology, Medical, Health Care Timothy Springer is an internationally recognized leader in structural biology and immunology. With over 500 peer-reviewed publications that have received over 90,000 citations, he is one of the most highly cited scientists in any field. Timothy Springer received his Ph.D. from Harvard University in 1976, and subsequent post-doctoral training withDr. Cesar Milstein in Cambridge, UK. Timothy Springer has been elected to the National Academy of Sciences and to the American Academy of Arts and Sciences. Among numerous awards and honors, Timothy Springer is a recipient of the Royal Society of Medicine Medal, the William B. Coley Medal from the Cancer Research Institute, and the Crafoord Prize from the Swedish Academy of Sciences. Timothy Springer's research laid the foundation for a new class of pharmaceuticals, the selective adhesion molecule inhibitors, which include the approved drugs, alefacept, efalizumab, and natalizumab. Timothy Springer was the Founder of LeukoSite, a biotechnology company acquired by Millennium Pharmaceuticals in 1999. LeukoSite developed therapeutics for inflammatory, autoimmune, and cancer applications, including FDA-approved Campath™. ## Stephen Siegel - Type: Angel - Location: New York, New York, United States - Relevant deals: 1 - Stages: Seed - Focus: Medical, Life Science, Biotechnology Stephen Siegel is Chairman of Global Brokerage at CBRE, the world’s largest real estate services company. In that capacity, he advises major corporations and property owners on a broad range of real estate issues. Mr. Siegel is widely regarded in commercial real estate circles as one of the industry’s most talented and prolific professionals. Hewas featured in the Urban Land Institute’s book, Leadership Legacies: Lessons Learned from Ten Real Estate Legends. Mr. Siegel was honored with Commercial Property News’ Lifetime Achievement Award and named by Crain’s as one of the 100 Most Influential Business Leaders in New York City. Prior to the merger with CBRE, as Chairman and CEO of Insignia/ESG, Mr. Siegel was largely responsible for masterminding the global expansion of the firm, nationwide as well as throughout Europe, Japan, Hong Kong, China, Thailand and Latin America. In that role, he also managed a group that completed approximately $2 billion in co-investments in a wide range of U.S. office, residential, hotel and retail real estate portfolios. Throughout his distinguished career, Mr. Siegel has arranged transactions for some of the nation’s most prominent corporate clients, among them, J.P. Morgan Chase & Co.; Sidley Austin Brown & Wood LLP; Fried Frank Harris Shriver & Jacobson LLP; Amerada Hess Corp.; Sanford C. Bernstein & Co.; Swiss Reinsurance; MetLife; Cerberus Capital Management; and Akin, Gump, Strauss, Hauer & Feld LLP. Websites featuring him: https://www.tenement.org/development_news/stephen-siegel/, ## Elliott Sigal - Type: Angel - Location: Princeton, New Jersey, United States - Relevant deals: 1 - Stages: Series A, Series B - Focus: Health Care, Biotechnology, Medical Elliott Sigal, M.D., Ph.D. joined NEA as a Venture Partner and Senior Advisor in 2014. He is a former Executive Vice President and Director of Bristol-Myers Squibb, and served as Chief Scientific Officer and President of R&D for Bristol-Myers Squibb from 2004 until 2013. He was a principal architect of the successful Biopharma TransformationStrategy of the company. He has been instrumental in increasing R&D productivity, developing the company’s strategy in biologics and acquiring external innovation in Bristol’s String of Pearls initiative. Under his leadership, fourteen new medicines have come to market including Abilify (Schizophrenia, Bipolar Disorder), Reyataz (HIV/AIDS), Erbitux (Colon Cancer), Baraclude (Hepatitis B), Orencia (Rheumatoid Arthritis), Sprycel (Leukemia), Atripla (HIV/AIDS), Ixempra (Breast Cancer), Onglyza and Kombiglyze (Diabetes), Nulojix (Transplantation), Eliquis (Anticoagulant), Yervoy (Melanoma), and Forxiga (Diabetes). Among his accomplishments in various therapeutic areas was building BMS research into a lead position in the promising area of immuno-oncology. In 2012, Dr. Sigal was named the best R&D chief in the pharmaceutical industry by Scrip Intelligence.Dr. Sigal currently serves as a senior advisor to the healthcare team of New Enterprise Associates and also consults for select biotechnology companies. Dr. Sigal received his M.D. from the University of Chicago in 1981 and trained in Internal Medicine and Pulmonary Medicine at the University of California, San Francisco (UCSF). Prior to medical school he studied engineering at Purdue University, where he received a B.S., M.S., and Ph.D. Dr. Sigal serves as a member of the Board of Directors for the Mead Johnson Nutrition Company and the Melanoma Research Alliance. ## Billy Hagstrom - Type: Angel - Location: Omaha, Nebraska, United States - Relevant deals: 1 - Stages: Pre-Seed - Focus: Life Science, Biotechnology Billy Hagstrom previously served as Executive Vice President of Strategy & Development for Green Plains, Inc.. Prior to moving to Omaha in 2021, Billy served as Chief Executive Officer of Cannalysis. Previously, Billy was a Managing Director at Highbridge Capital Management. Billy started in investment banking at J.P. Morgan focused on NaturalResources & Infrastructure. Billy earned his BA in Economics from Northwestern University. ## Jim Greer - Type: Angel - Location: San Francisco Bay Area, California, United States - Relevant deals: 1 - Stages: Seed - Focus: Health Care, Life Science, Biotechnology Jim Greer is the Chief Executive Officer at Bash. He was the co-founder and Chief Executive Officer of Kongregate. Before founding Kongregate in June 2006, Jim was Technical Director for Pogo at Electronic Arts. He has worked in the game industry since 1991. ## Domenic Merenda - Type: Angel - Location: Mountain View, California, United States - Relevant deals: 1 - Stages: Seed, Angel - Focus: B2B, Sales, Gaming Domenic Merenda is the Head of Science and Engineering for Sponsored Display Non-Endemic at Amazon. ## Daniel Goldman - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 1 - Stages: Seed, Series A, Convertible Note - Focus: Chemical, Biotechnology, Video Daniel Goldman Managing Partner of Ignition Angels/Keystone CatalystsA pioneer in online gaming and online communities, Daniel has a passion for applying technology to real world problems. He studied cognitive neuroscience at Columbia and became COO and VP PD at Posit Science, with Dr. Michael Merzenich, the world leading expert onneuroplasticity. There he incorporated the latest understanding of reward systems, neuroplasticity and the science of play into products for cognitive rehabilitation. Currently an angel investor, Daniel’s interest is for a world where everyone has ubiquitous access to opportunity, both social and economic, as well as freedom of thought. ## Joe Beverly - Type: Angel - Relevant deals: 1 - Stages: Pre-Seed, Series A - Focus: Marketing, Advertising, Life Science Joe Beverly ## Julia Popowitz - Type: Angel - Location: San Francisco, California, United States - Relevant deals: 1 - Stages: Seed, Series A, Pre-Seed - Focus: Software, Machine Learning, Artificial Intelligence Julia is an advisor to start ups and an active technology angel investor, with angel investments in Gusto, Lever, Baobab Studios, Brit Media, BetterUp, SafeGraph, CodeFights, AltSchool, MissionU, Owlet, Philz Coffee, Tynker, Happiest Baby, Kite, MileIQ (acq by MSFT), Locu (acq by GoDaddy), Beme (acq by CNN), Alt12 (acq by Honest Co), Worklife (acqby Cisco) & Wheelz (acq by Turo), and later stage investments in Uber, Alibaba (IPO’d), FlipKart, Postmates, DocuSign, Survey Monkey, Blue Bottle Coffee, Stripe and Spotify.Julia began her career as a corporate attorney at Wilson Sonsini Goodrich Rosati. In 2006, Julia joined Facebook as the second attorney in the legal department and led the commercial transactions team from June 2006 until April 2011. She negotiated numerous deals strategic to Facebook's growth and development, including with Microsoft, Spotify, ABC/Disney, CNN and YouTube. Julia led a team of 9 attorneys, oversaw Facebook's legal work related to its international expansion and operations, and worked on matters related to product and IP law. In her five years at Facebook, Julia was instrumental in scaling the legal team from two people to 40, setting up departmental procedures and infrastructure and hiring and managing outside counsel. Julia received her JD from Harvard Law School in 1997, graduating cum laude, and her BA from UC Berkeley, graduating magna cum laude and phi beta kappa with a degree in Political Science. She is a member of the State Bar of California.In her free time, Julia volunteers at her kids' schools and with other community organizations. She has chaired the annual auctions at Bing Nursery School and Nueva School and is on the National Council of World Wildlife Fund. Previously, she sat on the boards of the Oshman Family JCC, Hebrew Free Loan Association and Hands on Bay Area. She biked from SF to LA with the California AIDS Ride and ran the Honolulu Marathon with Team in Training.